Aline Rigon Zimmer

Dr. Aline Rigon Zimmer

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
IFIgor C. Fontana
Igor C. Fontana
AZAline Rigon Zimmer
Aline Rigon Zimmer
ARAndreia S. Rocha
Andreia S. Rocha
GGGrace Gosmann
Grace Gosmann
DSDiogo O. Souza
Diogo O. Souza
EZEduardo Zimmer
Eduardo Zimmer
Amyloid‐β (Aβ) dysmetabolism is tightly associated with pathological processes in Alzheimer's disease (AD). Currently, it is thought that, in addition to Aβ fibrils that give rise to plaque formation, Aβ aggregates into non‐fibrillar soluble oligomers (AβOs). Soluble AβOs have been extensively studied for their synaptotoxic and neurotoxic properties. In this review, we discuss physicochemical properties of AβOs and their impact on different brain cell types in AD. Additionally, we summarize three decades of studies with AβOs, providing a compelling bulk of evidence regarding cell‐specific mechanisms of toxicity. Cellular models may lead us to a deeper understanding of the detrimental effects of AβOs in neurons and glial cells, putatively shedding light on the development of innovative therapies for AD. image

1 January 2019 in Industrial Crops and Products
Verified
Journal Article
Closed access
RBRafael Gomes Von Borowski
Rafael Gomes Von Borowski
AZAline Rigon Zimmer
Aline Rigon Zimmer
BLBianca Franco Leonardi
Bianca Franco Leonardi
DTDanielle Silva Trentin
Danielle Silva Trentin
RSRodrigo Campos da Silva
Rodrigo Campos da Silva
AZAline Rigon Zimmer
Aline Rigon Zimmer

31 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JZJúlia Zilles
Júlia Zilles
LDLarissa Pedron Duarte
Larissa Pedron Duarte
TRThaís Carine Ruaro
Thaís Carine Ruaro
AZAline Rigon Zimmer
Aline Rigon Zimmer
Irene Clemes Clemes Külkamp - GuerreiroIrene Clemes Clemes Külkamp - Guerreiro
Irene Clemes Clemes Külkamp - Guerreiro
Renata Vidor ContriRenata Vidor Contri
Renata Vidor Contri
Melasma is a hard-to-treat hyperpigmentation disorder. Combined incorporation of kojic dipalmitate (KDP), the esterified form of kojic acid, and rosehip oil, an oil with antioxidant and skin-regenerating properties, into nanocarrier systems appears to be a suitable strategy to develop high-performance formulations. A high-energy method (Ultra-Turrax®) was used to develop nanoemulsions containing up to 2 mg/mL KDP, 5% rosehip oil, and 7.5% surfactant. Formulations were characterized regarding droplet size, size distribution, pH, density, morphology, KDP content, incorporation efficiency, and stability under different temperature conditions. A scale-up study was conducted. Skin permeation, antioxidant potential, and tyrosinase inhibitory activity were assessed in vitro. Cell viability studies were also performed. Results showed that nanoemulsions containing 1 and 2 mg/mL KDP had incorporation efficiencies greater than 95%, droplet size smaller than 130 nm, suitable size distribution, zeta potential of approximately −10 mV, and good stability over 30 days of refrigerated storage. The nanoemulsion containing 1 mg/mL KDP was chosen for further evaluation because it had lower nanocrystal formation, greater scale-up feasibility and allowed KDP permeation up to the epidermis similarly than observed for 2 mg/mL KDP. This formulation (1 mg/mL KDP) showed antioxidant and depigmenting efficacy, close to that of 1 mM ascorbic acid. No cytotoxicity was observed in formulations concentrations ranging from 0.06% to 1%.

20 October 2014 in Pharmaceutical Biology
Verified
Journal Article
Closed access
PDF file
Laura SilvaLaura Silva
Laura Silva
DTDanielle Federal de Ciências da saúde de Porto Alegre Trentin
Danielle Federal de Ciências da saúde de Porto Alegre Trentin
AZAline Rigon Zimmer
Aline Rigon Zimmer
JTJanine Treter
Janine Treter
CBClara Lia Costa Brandelli
Clara Lia Costa Brandelli
AMAlexandre Macedo
Alexandre Macedo
Context: The local communities living in the Brazilian Caatinga biome have a significant body of traditional knowledge on a considerable number of medicinal plants used to heal several maladies. Objective: Based on ethnopharmacological data, this study screened 23 aqueous plant extracts against two well-known models of biofilm-forming bacteria: Staphylococcus epidermidis and Pseudomonas aeruginosa. Materials and methods: Crystal violet assay and scanning electron microscopy (SEM) were used to evaluate the effect of extracts on biofilm formation and measurements of the absorbance at 600 nm to assess bacterial growth. Selected extracts were investigated regarding the cytotoxicity by MTT assay using mammal cells and the qualitative phytochemical fingerprint by thin layer chromatography. Results: Harpochilus neesianus Mart. ex Nees. (Acanthaceae) leaves, Apuleia leiocarpa Vogel J. F. Macbr. (Fabaceae), and Poincianella microphylla Mart. ex G. Don L. P. Queiroz (Fabaceae) fruits showed non-biocidal antibiofilm action against S. epidermidis with activities of 69, 52, and 63%, respectively. SEM confirmed that biofilm structure was strongly prevented and that extracts promoted overproduction of the matrix and/or bacterial morphology modification. Poincianella microphylla demonstrated toxicity at 4.0 mg/mL and 2.0 mg/mL, A. leiocarpa presented toxicity only at 4.0 mg/mL, whereas H. neesianus presented the absence of toxicity against Vero cell line. Preliminary phytochemical analysis revealed the presence of flavonoids, terpenoids, steroids, amines, and polyphenols. Discussion and conclusions: This work provides a scientific basis which may justify the ethnopharmacological use of the plants herein studied, indicating extracts that possess limited mammal cytotoxicity in vitro and a high potential as a source of antibiofilm drugs prototypes.

25 September 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
BLBianca F. Leonardi
Bianca F. Leonardi
GGGrace Gosmann
Grace Gosmann
AZAline Rigon Zimmer
Aline Rigon Zimmer

1 August 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AZAline Rigon Zimmer
Aline Rigon Zimmer
MBMiled Bourourou
Miled Bourourou
FLFrédéric Lesage
Frédéric Lesage
EHEdith Hamel
Edith Hamel
INTRODUCTION: Alzheimer's disease (AD) is a leading cause of dementia, with vascular dysfunction being an early pathogenic event. Cardiovascular interventions show therapeutic promise, hence may improve neurovascular coupling (NVC) and resting‐state functional connectivity (RSFC) hemodynamic responses.METHODS: NVC and RSFC were recorded longitudinally in control and AD transgenic mice treated or not with simvastatin (SV) using optical imaging of intrinsic signals (OIS), together with memory testing.RESULTS: AD mice showed early decreases in NVC and bilateral connectivity (BC) in motor and cingulate cortex, and hypoconnectivity within the sensory‐motor network. Early default‐mode network (DMN) hyperconnectivity was followed by hypoconnectivity, together with a decreased BC in somatosensory (S) cortex. SV restored NVC, prevented aberrant DMN hyperconnectivity, improved BC of S, and preserved memory.DISCUSSION: Our results indicate that OIS can detect early AD‐related changes in NVC and RSFC, and that a preventive cardiovascular strategy may bear therapeutic promise in at‐risk individuals.Highlights: Optical imaging of intrinsic signals captures Alzheimer's disease (AD) progression and response to therapy. Neurovascular coupling (NVC) and resting‐state functional connectivity (RSFC) disruptions precede memory decline in AD transgenic mice. Simvastatin prevented NVC and AD‐specific RSFC disruptions and protected memory. This study supports translational value of hemodynamic signal in early AD detection.